Suppression of 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced skin inflammation in mice by transduced Tat-Annexin protein

BMB Reports

Volumn 45, Issue 6, 2012, Pages 354-359

  Lee, Sun Hwa ^a   Kim, Dae Won ^a   Eom, Seon Ae ^a   Jun, Se Young ^a   Park, Meeyoung ^a   Kim, Duk Soo ^b   Kwon, Hyung Joo ^a   Kwon, Hyeok Yil ^a   Han, Kyu Hyung ^a   Park, Jinseu ^a   Hwang, Hyun Sook ^a   Eum, Won Sik ^a   Choi, Soo Young ^a  

^a Hallym University   (South Korea)

^b Soonchunhyang University   (South Korea)

Author keywords

Cytokine; Inflammation; MAPK; Tat ANX1; TPA

Indexed keywords

ANNEXIN; CYCLOOXYGENASE 2; HYBRID PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 1BETA; INTERLEUKIN 6; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE P38; PHORBOL 13 ACETATE 12 MYRISTATE; TAT ANX1 FUSION PROTEIN; TAT-ANX1 FUSION PROTEIN; TRANSACTIVATOR PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; EDEMA; INSTITUTE FOR CANCER RESEARCH MOUSE; MALE; METABOLISM; MOUSE; PHOSPHORYLATION; SKIN DISEASE;

ANIMALS; ANNEXINS; CYCLOOXYGENASE 2; EDEMA; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE PRODUCTS, TAT; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MICE; MICE, INBRED ICR; NF-KAPPA B; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; RECOMBINANT FUSION PROTEINS; SKIN DISEASES; TETRADECANOYLPHORBOL ACETATE; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; MUS;

EID: 84864385624     PISSN: 19766696     EISSN: 1976670X     Source Type: Journal    
DOI: 10.5483/BMBRep.2012.45.6.036     Document Type: Article

References (29)

1. Bertolini, A., Ottani, A. and Sandrini, M. (2002) Selective COX-2 inhibitors and dual acting anti-inflammatory drugs: critical remarks. Curr. Med. Chem. 9, 1033-1043.
2. Firestein, G. S. (2003) Evolving concepts of rheumatoid arthritis. Nature 423, 356-361.
3. Korhonen, R., Lathi, A., Kankaanranta, H. and Moilanen, E. (2005) Nitric oxide production and signaling in inflammation. Curr. Drug Targets Inflamm. Allergy 4, 471-479.
4. Libby, P., Ridker, P. M. and Maseri, A. (2000) Inflammation and atherosclerosis. Circulation 105, 1135-1143.
5. Cho, H. J., Seon, M. R., Lee, Y. M., Kim, J., Kim, J. K., Kim, S. G. and Park, J. H. (2008) 3,3'-Diindolylmethane suppresses the inflammatory response to lipopolysaccharide in murine macrophage. J. Nutr. 138, 17-23.
6. Tilley, S. L., Coffman, T. M. and Koller, B. A. (2001) Mixed message gene: modulation of inflammation and immune responses by prostaglandins and thromboxanes. J. Clin. Invest. 107, 191-195.
7. Carey, M. A., Germolec, D. R., Langenbach, R. and Zeldin, D. C. (2003) Cyclooxygenase enzymes in allergic inflammation and asthma. Prostaglandins Leukot Essent Fatty Acids 69, 157-162.
8. Lee, E., Choi, M. K., Lee, Y. J., Ku, J. L., Kim, K. H., Choi, J. S. and Lim, S. J. (2006) Alpha-tocopheryl succinate, in contrast to alpha-tocopherol and alpha-tocopheryl acetate, inhibits prostaglandin E2 production in human lung epithelial cells. Carcinogen 27, 2308-2315.
9. Vancheri, C., Mastruzzo, C., Sortino, M. A. and Crimi, N. (2004) The lung as a privileged site for the beneficial actions of PEG2. Trends Immunol. 25, 40-46.
10. Buchanan, M. M., Hutchinson, M., Watkins, L. R. and Yin, H. (2010) Toll-like receptor 4 in CNS pathologies. J. Neurochem. 114, 13-27.
11. Mararov, S. S. (2000) NF-κB as a therapeutic target in chronic inflammation: recent advances. Mol. Med. Today 6, 441-448.
12. Babbin, B., Laukoetter, M. G., Nava, P., Koch, S., Lee, W. Y., Capaldo, C. T., Peatman, E., Severson, E. A., Flower, R. J., Perretti, M., Parkos, C. A. and Nusrat, A. (2008) Annexin A1 regulates intestinal mucosal injury, inflammation, and repair. J. Immunol. 181, 5035-5044.
13. Kamal, A. M., Flower, R. J. and Perretti, M. (2005) An overview of the effects of annexin 1 on cells involved in the inflammatory process. Mem. Inst. Oswaldo Cruz Rio de Janeiro 100(Suppl 1), 39-48.
14. Perretti, M. and D'Acquisto, F. (2009) Annexin A1 and glucocorticoids as effectors of the resolution of inflammation. Nat. Rew. Immunol. 9, 62-70.
15. Wadia, J. and Dowdy, S. F. (2002) Protein transduction technology. Curr. Opin. Biotechnol. 13, 52-56.
16. Ahn, E. H., Kim, D. W., Kang, H. W., Shin, M. J., Won, M. H., Kim, J., Kim, D. J., Kwon, O. S., Kang, T. C., Han, K. H., Park, J., Eum, W. S. and Choi, S. Y. (2010) Transduced PEP-1-ribosomal protein S3 (rpS3) ameliorates 12-O-tetradecanoylphorbol-13-acetate-induced inflammation in mice. Toxicol. 276, 192-197.
17. An, J. J., Lee, Y. P., Kim, S. Y., Lee, S. H., Lee, M. J., Jeong, M. S., Kim, D. W., Jang, S. H., Yoo, K. Y., Won, M. H., Kang, T. C., Kwon, O. S., Cho, S. W., Lee, K. S., Park, J., Eum, W. S. and Choi, S. Y. (2008) Transduced human PEP-1-heat shock protein 27 efficiently protects against brain ischemic insult. FEBS J. 275, 1296-1308.
18. Kim, D. W., Jeong, H. J., Kang, H. W., Shin, M. J., Sohn, E. J., Kim, M. J., Ahn, E. H., An, J. J., Jang, S. H., Yoo, K. Y., Won, M. H., Kang, T. C., Hwang, I. K., Kwon, O. S., Cho, S. W., Park, J., Eum, W. S. and Choi, S. Y. (2009) Transduced PEP-1-catalase fusion protein attenuates ischemic neuronal damage. Free Radic. Biol. Med. 47, 941-952.
19. Lee, S. H., Jeong, H. J., Kim, D. W., Sohn, E. J., Kim, M. J., Kim, D. S., Kang, T. C., Lim, S. S., Kang, I. J., Cho, S. W., Lee, K. S., Park, J., Eum, W. S. and Choi, S. Y. (2010) Enhancement of HIV-1 Tat fusion protein transduction efficiency by bog blueberry anthocyanins. BMB Rep. 43, 561-566.
20. Lee, S. H., Kim, D. W., Back, S. S., Hwang, H. S., Park, E. Y., Kang, T. C., Kwon, O. S., Park, J. H., Cho, S. W., Han, K. H., Park, J., Eum, W. S. and Choi, S. Y. (2011) Transduced Tat-annexin protein suppresses lipopolysaccharide (LPS)-stimulated inflammation gene expression in Raw 264.7 cells. BMB Rep. 44, 484-489.
21. Stanley, P. L., Steiner, S., Havens, M. and Tramposch, K. M. (1991) Mouse skin inflammation induced by multiple topical applications of 12-O-tetradecanoylphorbol-13-acetate. Skin Pharmacol. 4, 262-271.
22. DeVry, C. G., Valdez, M., Lazarov, M., Muhr, E., Buelow, R., Fong, T. and Iyer, S. (2005) Topical application of a novel immunomodulatory peptide, RDP58, reduces skin inflammation in the phorbol ester-induced dermatitis model. J. Invest. Dermatol. 125, 473-481.
23. Ha, H. Y., Kim, Y., Ryoo, Z. Y. and Kim, T. Y. (2006) Inhibition of the TPA-induced cutaneous inflammation and hyperplasia by EC-SOD. Biochem. Biophys. Res. Commun. 348, 450-458.
24. Murakawa, M., Yamaoka, K., Tanaka, Y. and Fukuda, Y. (2006) Involvement of tumor necrosis factor (TNF)-a in phorbol ester 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced skin edema in mice. Biochem. Pharmacol. 71, 1331-1336.
25. Flower, R. J. (1988) Lipocortin and the mechanism of action of the glucocorticoid. Br. J. Pharmacol. 94, 987-1015.
26. Chiang, N., Fierro, I. M., Gronert, K. and Serhan, C. N. (2000) Activation of lipoxin A4 receptors by aspirin-triggered lipoxins and select peptides evokes ligands-specific responses in inflammation. J. Exp. Med. 191, 1197-1208.
27. Kieran, N. E., Doran, P. P., Connolly, S. B., Greenan, M. C., Higgins, D. F., Leonard, M., Godson, C., Taylor, C. T., Henger, A., Kretzler, M., Burne, M. J., Rabb, H. and Brady, H. R. (2003) Modification of the transcriptomic response to renal ischemia/reperfusion injury by lipoxin analog. Kidney Int. 64, 480-492.
28. Gayathri, B., Manjula, N., Vinaykumar, K. S., Lakshmi, B. S. and Balakrishnan, A. (2007) Pure compound from Boswellia serrata extract exhibits anti-inflammatory property in human PBMCs and mouse macrophages through inhibition of TNF-α, IL-1β, NO and MAP kinases. Int. Immunopharmacol. 7, 473-482.
29. Bradford, M. A. (1976) A rapid and sensitive method for the quantification of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem. 72, 248-254.